HOUSTON – Aug. 12, 2025 – Global law firm Greenberg Traurig, LLP represented digital health company Analyte Health in its sale to private equity firm Brightstar Capital Partners. Renowned for its digital health platform to conveniently access diagnostic and treatment services, Analyte Health leverages a proprietary technology platform and a robust network of partner laboratories and clinicians.
Greenberg Traurig advised Analyte Health on all regulatory aspects of the transaction, including advising on compliance with federal and state health care laws related to telehealth and laboratory services, data privacy, and provider relationships. The acquisition of Analyte Health represents the continued growth in the consumer-initiated health care sector.
The Greenberg Traurig team was led by Health Care & FDA Practice Shareholder Charles C. Dunham, IV, who is based in the firm’s Houston office.
“We are honored to support Analyte Health during this important transaction and thank their owner and executive team for trusting us with its legal needs over many years. It is our honor to support the work of Analyte Health’s founder, Fiyyaz Pirani, through the company’s growth and in connection with this transaction,” Dunham said.
Read the press release issued by Brightstar Capital Partners.